Alexander J. Reuss
Philipps Universitaet Marburg, Karl Von Frisch Str. 4
Marburg An Der Lahn, HE 35043, Germany
Marburg An Der Lahn, HE 35043, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 03, 2025
Prenatal diagnosis of Blepharo-Cheilo-Dontic syndrome: a case report.
Journal: Archives of gynecology and obstetrics
Published: September 08, 2025
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 15, 2025
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysis.
Journal: International journal of surgery (London, England)
Published: November 30, 2024
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 25, 2024
Detection of human cytomegalovirus cell-free DNA in pregnant women with symptomatically infected fetuses: proof-of-concept study.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: September 06, 2024
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: November 07, 2023
Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial.
Journal: The British journal of dermatology
Published: August 31, 2023
Cytoreductive Surgery for Relapsed Ovarian Cancer. Reply.
Journal: The New England journal of medicine
Published: March 02, 2022
Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial.
Journal: BMC cancer
Published: January 25, 2022
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Journal: The Lancet. Oncology
Published: January 20, 2022
Last Updated: 09/26/2026